What is it about?
Medication non-adherence is a common problem among patients with diabetes. Patient-reported medication adherence scales are the most commonly used method to assess patient medication adherence, but up to today there is no specific tool for assessing medication adherence among patients with diabetes in Arab countries.
Featured Image
Photo by Thought Catalog on Unsplash
Why is it important?
The present study also showed that the IADMAS had greater sensitivity and specificity than the MAQ (100% vs 87.5% and 33.9% vs 29.7%, respectively), and this finding may confirm that the IADMAS could be more specific for Iraqi patients with DM since the MAQ was a general tool for assessing adherence.
Perspectives
Writing this article was a great pleasure as it has co-authors with whom I have had long standing collaborations. This article also lead to work with diabetic patients and ultimately to a greater involvement in the efforts aimed to implant programs that help those patients to effectively adhere to their treatment protocols..
Professor Saad Abdulrahman Hussain
Al-Rafidain University College, Faculty of Pharmacy, Baghdad, Iraq
Read the Original
This page is a summary of: Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study, BMJ Open Diabetes Research & Care, July 2019, BMJ,
DOI: 10.1136/bmjdrc-2019-000658.
You can read the full text:
Contributors
The following have contributed to this page
